Literature DB >> 2850475

Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha.

D Defeo-Jones1, J Y Tai, R J Wegrzyn, G A Vuocolo, A E Baker, L S Payne, V M Garsky, A Oliff, M W Riemen.   

Abstract

Transforming growth factor alpha (TGF-alpha) is a 50-amino-acid peptide that stimulates cell proliferation via binding to cell surface receptors. To identify the structural features of TGF-alpha that govern receptor-ligand interactions, we prepared synthetic peptide fragments and recombinant mutant proteins of TGF-alpha. These TGF-alpha derivatives were tested in receptor binding and mitogenesis assays. Synthetic peptides representing the N terminus, the C terminus, or the individual disulfide constrained rings of TGF-alpha did not exhibit receptor-binding or mitogenic activity. Replacement of the cysteines with alanines at positions 8 and 21, 16 and 32, and 34 and 43 or at positions 8 and 21 and 34 and 43 yielded inactive mutant proteins. However, mutant proteins containing substitutions or deletions in the N-terminal region retained significant biologic activity. Conservative amino acid changes at residue 29 or 38 or both and a nonconservative amino acid change at residue 12 had little effect on binding or mitogenesis. However, nonconservative amino acid changes at residues 15, 38, and 47 produced dramatic decreases in receptor binding (23- to 71-fold) and mitogenic activity (38- to 125-fold). These studies indicate that at least three distinct regions of TGF-alpha contribute to biologic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850475      PMCID: PMC363525          DOI: 10.1128/mcb.8.8.2999-3007.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Epidermal growth factor. Location of disulfide bonds.

Authors:  C R Savage; J H Hash; S Cohen
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

3.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

4.  Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers.

Authors:  A K Ahmed; S W Schaffer; D B Wetlaufer
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

5.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor.

Authors:  H Marquardt; M W Hunkapiller; L E Hood; G J Todaro
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

6.  Human transforming growth factor-alpha: precursor structure and expression in E. coli.

Authors:  R Derynck; A B Roberts; M E Winkler; E Y Chen; D V Goeddel
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

7.  Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides.

Authors:  J Rivier; R McClintock; R Galyean; H Anderson
Journal:  J Chromatogr       Date:  1984-04-24

8.  Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha.

Authors:  D C Lee; T M Rose; N R Webb; G J Todaro
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

9.  Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors.

Authors:  M C Blomquist; L T Hunt; W C Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Assessment of biological activity of synthetic fragments of transforming growth factor-alpha.

Authors:  K Darlak; G Franklin; P Woost; E Sonnenfeld; D Twardzik; A Spatola; G Schultz
Journal:  J Cell Biochem       Date:  1988-04       Impact factor: 4.429

View more
  7 in total

1.  Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Authors:  J A Feild; R H Reid; D J Rieman; T P Kline; G Sathe; R G Greig; M A Anzano
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds.

Authors:  D Defeo-Jones; J Y Tai; G A Vuocolo; R J Wegrzyn; T L Schofield; M W Riemen; A Oliff
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.

Authors:  G P Briley; M A Hissong; M L Chiu; D C Lee
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

4.  Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.

Authors:  D A Engler; M R Hauser; J S Cook; S K Niyogi
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.

Authors:  S M A Bastaki; S I Chandranath; J Singh
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

6.  Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor-alpha-Pseudomonas exotoxin fusion proteins.

Authors:  G M Edwards; D DeFeo-Jones; J Y Tai; G A Vuocolo; D R Patrick; D C Heimbrook; A Oliff
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 5.069

7.  Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts.

Authors:  D C Heimbrook; S M Stirdivant; J D Ahern; N L Balishin; D R Patrick; G M Edwards; D Defeo-Jones; D J FitzGerald; I Pastan; A Oliff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.